Elekta’s Q3 sales spike, earnings soar

Elekta (STO:EKTA B) raised its 3rd-quarter sales by 40.8% and saw profits more than double for the 3 months ended Jan. 31.

The Swedish medical device maker posted profits of $57.8 million (SEK392 million), or 61 cents (SEK4.14) per share, on sales of $378.0 million (SEK2.37 billion) during the quarter.

That compares with profits of $28.7 million (SEK195 million), or 30 cents (SEK2.06) per share, on sales of $268.5 million (SEK1.82 billion) in the same period during the prior year. Read more

 Essilor’s 2011 sales, earnings rise
French ophthalmic device maker Essilor (EPA:EI) posted profits of $663.5 million (€505.6 million), or $3.16 (€2.41) per share, on sales of $5.50 billion (€4.19 billion) during 2011.

That compares with profits of $606.2 million (€462.0 million), or $2.86 (€2.18) per share, on sales of $5.11 billion (€3.89 billion) during the same period last year. Read more

 DGT’s sales rise, profits soar on divestiture

DGT Holdings (OTC:DGTC) posted profits of $7.8 million, or $2.02 per share, on sales of $3.0 million during the 3 months ended Jan. 28.

That compares with profits of $1.1 million, or 43 cents per share, on sales of $2.5 million during the same period last year. Read more

Sign up to get our free newsletters delivered straight to your inbox

 Q4, 2011 sales slump, losses widen for Stereotaxis

Stereotaxis (NSDQ:STXS) posted losses of $5.5 million, or 10 cents per share, on sales of $4.2 million during the 3 months ended Dec. 31, 2011.

That compares with losses of $2.5 million, or 5 cents per share, on sales of $8.3 million during the same period in 2010.

For the full year, Stereotaxis reported losses of $32.0 million, or 38 cents per share, on sales of $15.6 million. That compares with losses of $19.9 million, or 39 cents per share, on sales of $31.1 million during 2010. Read more

 Sales, earning slide for Iridex in Q4

Iridex (NSDQ:IRIX) posted profits of $786,000, or 8 cents per share, on sales of $8.6 million during the 3 months ended Dec. 31, 2011.

That compares with profits of $837,000, also 8 cents per share, on sales of $9.0 million during the same period in 2010.

For the full year, Iridex reported profits of $2.6 million, or 26 cents per share, on sales of $33.2 million. That compares with profits of $3.0 million, or 30 cents per share, on sales of $32.3 million during 2010. Read more

 Losses soar for Imris in 2011

Imris (NSDQ:IMRS) posted losses of $20.9 million, or 47 cents per share, on sales of $51.8 million during 2011.

That compares with losses of $1.8 million, or 5 cents per share, on sales of $70.3 million during 2010. Read more

 CasMed’s sales slide, losses widen for Q4, 2011

CAS Medical Systems (NSDQ:CASM) posted losses of $2.0 million, or 15 cents per share, on sales of $5.3 million during the 3 months ended Dec. 31, 2011.

That compares with losses of $1.0 million, or 8 cents per share, on sales of $5.9 million during the same period in 2010.

For the full year, CasMed logged losses of $6.7 million, or 51 cents per share, on sales of $22.5 million. That compares with losses of $1.3 million, or 11 cents per share, on sales of $24.1 million during 2010. Read more

 Oridion’s 2011 sales rise, profits slide

Oridion (SWF:ORIDN) posted profits of $6.4 million, or 46 cents per share, on sales of $64.5 million during 2011.

That compares with profits of $7.7 million, or 57 cents per share, on sales of $54.2 million during 2010. Read more